Brief: Imugene Says Oncarlytics Patent Allowance In China
26/02/2025 01:58
Feb 26 (Reuters) - Imugene Ltd IMU.AX: ONCARLYTICS PATENT ALLOWANCE IN CHINA Source text: ID:nASX4H7R2B Further company coverage: IMU.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imugene
See all newsAustralia's Imugene rises on fresh responses in blood cancer drug trial
Brief: Imugene Ltd Says Leslie Chong Resigns As CEO
Australia's Imugene loses most in over 8-years on discounted placement
Brief: Imugene To Raise A$11.12 Million Via Placement At A$0.095 Per Share
Brief: Imugene Requests Trading Halt Pending Proposed Capital Raising Announcement